{"name":"Vatera Healthcare Partners","permalink":"vatera-healthcare-partners","crunchbase_url":"http://www.crunchbase.com/financial-organization/vatera-healthcare-partners","homepage_url":"","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"212-590-2950","description":"A venture capital firm","email_address":"","number_of_employees":null,"founded_year":2007,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Wed Dec 14 04:56:44 UTC 2011","updated_at":"Fri Jun 08 11:56:30 UTC 2012","overview":"<p>Vatera Healthcare Partners is a venture capital firm specializing in investment in biopharmaceutical firms and products and in companies that develop innovative products for unmet and underserved medical needs. The firm was founded in 2007 and is based in New York, New York.</p>","image":null,"offices":[{"description":"","address1":"499 Park Avenue","address2":"23rd Floor","zip_code":"10022","city":"New York","state_code":"NY","country_code":"USA","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"a","source_url":"http://www.prnewswire.com/news-releases/immusant-raises-20-million-in-series-a-financing-to-advance-immunotherapeutic-and-diagnostic-for-celiac-disease-135496313.html","source_description":"ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":12,"funded_day":13,"company":{"name":"ImmusanT","permalink":"immusant","image":{"available_sizes":[[[150,33],"assets/images/resized/0016/6330/166330v1-max-150x150.png"],[[250,55],"assets/images/resized/0016/6330/166330v1-max-250x250.png"],[[389,86],"assets/images/resized/0016/6330/166330v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/pearl-lands-69m-series-c-mid-stage-copd-program/2010-10-19?utm_medium=rss&utm_source=rss","source_description":"Pearl lands $69M Series C for mid-stage COPD program","raised_amount":69000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":19,"company":{"name":"Pearl Therapeutics","permalink":"pearl-therapeutics","image":{"available_sizes":[[[150,56],"assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2012/11/pearl-therapeutics-raises-65m-series-financing.html","source_description":"Pearl Therapeutics Raises $65M in Series D Financing","raised_amount":65000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":13,"company":{"name":"Pearl Therapeutics","permalink":"pearl-therapeutics","image":{"available_sizes":[[[150,56],"assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.masshightech.com/stories/2012/11/26/daily39-Rib-X-closes-first-tranche-of-675M-financing.html","source_description":"Rib-X closes first tranche of $67.5M financing","raised_amount":67500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":29,"company":{"name":"Rib-X Pharmaceuticals","permalink":"rib-x-pharmaceuticals","image":{"available_sizes":[[[150,49],"assets/images/resized/0004/1688/41688v1-max-150x150.png"],[[250,82],"assets/images/resized/0004/1688/41688v1-max-250x250.png"],[[282,93],"assets/images/resized/0004/1688/41688v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}